Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Tools
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
401k Retirement Calculator
Mortgage Calculator
Popular
Compound Interest Calculator
Dollar Cost Averaging
New
Student Loan Calculator
Auto Loan Calculator
Personal Finance
News
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us
More
Plans
News
Smart Portfolio
Expert Center
TipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed Tools
Try Now
Ideas
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Tools
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us
FHTX
Stock Latest News
Company Announcements
Foghorn Therapeutics Appoints Kristian Humer as New CFO
9d ago
8K
FHTX
Premium
The Fly
Foghorn Therapeutics appoints Humer as Chief Financial Officer
9d ago
FHTX
VRDN
Premium
Company Announcements
Foghorn Therapeutics Unveils Cancer Research Breakthroughs
16d ago
8K
FHTX
Premium
Press Releases
Foghorn Therapeutics Presents New Preclinical Data on Potential First-in-Class BRM Selective Inhibitor FHD-909 and Selective CBP and Selective EP300 Degrader Oncology Programs
16d ago
FHTX
Premium
Press Releases
Foghorn Therapeutics to Participate in Needham’s 23rd Annual Virtual Healthcare Conference
20d ago
FHTX
Premium
Press Releases
Foghorn to Host Conference Call and Webcast on Pipeline of Potential First-in-Class Medicines in Conjunction with the 2024 AACR Annual Meeting
1M ago
FHTX
Premium
Company Announcements
Foghorn Therapeutics Unveils New Investor Presentation
2M ago
8K
FHTX
Premium
Press Releases
Foghorn Therapeutics Provides Financial Update for 2023 and 2024 Strategic Outlook
2M ago
FHTX
Premium
The Fly
Foghorn Therapeutics expects cash runway into first half of 2026
2M ago
FHTX
Premium
The Fly
Foghorn Therapeutics reports FY23 EPS ($2.34), consensus ($2.48)
2M ago
FHTX
Premium
The Fly
Foghorn Therapeutics, Eli Lilly to present new preclinical data at AACR
2M ago
LLY
FHTX
Premium
Press Releases
Foghorn Therapeutics to Present New Preclinical Data at 2024 AACR Annual Meeting, Reflecting Advances with Multiple Potential First-in-Class Medicines, including the Selective Inhibitor of BRM, FHD-909
2M ago
FHTX
Premium
Pre-Earnings
Is FHTX a Buy, Before Earnings?
2M ago
FHTX
Premium
Company Announcements
Foghorn’s FHD-909 Advances to Clinical Trials with Eli Lilly
3M ago
8K
FHTX
Premium
Company Announcements
Foghorn Therapeutics Releases New Investor Presentation
3M ago
8K
FHTX
Premium
The Fly
Foghorn Therapeutics says Lilly selects FHD-909 for clinical development
3M ago
LLY
FHTX
Premium
The Fly
Foghorn Therapeutics announces strategic objectives for 2024
4M ago
FHTX
Premium
The Fly
Prime Medicine appoints Reine as Chief Financial Officer
4M ago
FHTX
PRME
Premium
The Fly
Foghorn Therapeutics CFO Allan Reine to depart
4M ago
FHTX
Premium
Press Releases
Foghorn Therapeutics Provides Third Quarter 2023 Financial and Corporate Update
6M ago
FHTX
Premium
The Fly
Foghorn Therapeutics expects cash to fund operations into 1H26
6M ago
FHTX
Premium
The Fly
Foghorn Therapeutics reports Q3 EPS (34c), consensus (75c)
6M ago
FHTX
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
